Cardiol Therapeutics INc. (CRDL-T) Stock Predictions - Stockchase
WATCH LIST
2
Cardiol Therapeutics INc. (CRDL-T)

ON STOCKCHASE SINCE Feb 2019

biotechnology

Cardiol Therapeutics INc.

CRDL-T

3 watching          
Join the Discussion

Cardiol Therapeutics INc. (CRDL-T) SAVE Mar, 18, 2019, 3:05 pm

5.77 0.22 (3.67%)

What the experts are saying about CRDL-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
They struck a deal with Noramco, to sell into Canada and Mexico, synthetic CPD (for heart medication). They have enough cash to self finance the heart research.
biotechnology
0 0 0 0 0
0 comments
They struck a deal with Noramco, to sell into Canada and Mexico, synthetic CPD (for heart medication). They have enough cash to self finance the heart research.
biotechnology
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$5.770
Owned Owned
Unknown

HOLD
He has met management twice and they had their IPO in mid-December. They have looked into the use of CBD to use as an anti-inflammatory for heart patients. They are working on developing synthetic CBD. They think they could produce 1 millions grams of CBD this year. This creates a great opportunity and they have enough technology to advance their strategy. If they can sell the CBC, the company is fairly valued.
biotechnology
0 0 0 0 0
0 comments
He has met management twice and they had their IPO in mid-December. They have looked into the use of CBD to use as an anti-inflammatory for heart patients. They are working on developing synthetic CBD. They think they could produce 1 millions grams of CBD this year. This creates a great opportunity and they have enough technology to advance their strategy. If they can sell the CBC, the company is fairly valued.
biotechnology
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$6.620
Owned Owned
Unknown

Showing 1 to 2 of 2 entries
Successfully Saved Company
Successfully Saved Company